Fierce Health Technology October 18, 2019
NEW YORK CITY—Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma said the Trump administration wants to move forward on a value-based pricing approach to pharmaceuticals to help curb the high cost of drugs.
Verma said drugs represent one of the fastest-growing costs for CMS.
“We’re seeing price tags of 1 million to 2 million dollars; that’s not sustainable,” Verma said while being interviewed at the TIME 100 Health Summit Thursday. “We want to encourage innovation, but that doesn’t mean anything if people can’t access the medications.”
The Trump administration is focused on targeting the cost of physician-administered drugs, Verma said. “Part of the problem is the way the government pays for some of these drugs. We’re the largest...
Today's Sponsors
Today's Sponsor